The role of CCL-2 in the progression of pancreatic cancer has been of high interest for investigators given its potent induction of monocyte migration to the tumor site, and the production of CCL-2 correlates with macrophage presence in transplanted in vivo tumors [107,108,109]. Here, CCL2 is linked to familial pancreatic carcinoma.